<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01559324</url>
  </required_header>
  <id_info>
    <org_study_id>6.2009.06 2011/02/0009</org_study_id>
    <nct_id>NCT01559324</nct_id>
  </id_info>
  <brief_title>Electroconvulsive Therapy (ECT) for Elderly Patients With Major Depression</brief_title>
  <official_title>Randomized Controlled Comparison of Bifrontal and Right Unilateral ECT as to Effects on Depression, Global Cognitive Function and Biomarkers.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Diakonhjemmet Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>MD Tor Magne Bjølseth</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>MD Torfinn Lødøen Gaarden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Diakonhjemmet Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      ECT (electroconvulsive therapy) is mostly given to patients between the age of 60 - 85 years.
      There is limited evidence on the efficacy and cognitive side-effects of right unilateral (RU)
      and bifrontal (BF) electrode positions, the placements that are considered safe for the
      elderly. As far as the investigators know no randomized controlled trials (RCTs) have yet
      been published describing this population treated with BF or RU ECT. Non-demented depressed
      patients will be randomized to either method (n = 2x36). Symptom intensity, global cognitive
      function and biomarkers will be related to 20 healthy comparators. Testing, evaluation of
      depression and blood-tests are done before ECT-treatment, after a series of 6-16 ECT and 3
      months after terminated ECT-treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients are assessed with Mini Mental Status Examination. Postictal reorientation time is
      measured. There is also a weekly rating of depression depth during the series. After the 6th
      ECT; Mini Mental Status Examination For a subgroup of patients; extensive blood-test samples
      are taken on the day of the 6th ECT.

      Some of the patients receive continuation-ECT once monthly after the series. In these months
      patients receive treatment as usual (naturalistic observation).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2009</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Depression</measure>
    <time_frame>5 months</time_frame>
    <description>Hamilton depression Scale 17 items (HAM-D-17), Montgomery Åsberg Depression Rating Scale (MADRS)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cognitive function</measure>
    <time_frame>5 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood-tests</measure>
    <time_frame>5 months</time_frame>
    <description>Cytokines, complement factors, BDNF, S-100-beta among others</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">92</enrollment>
  <condition>Major Depression</condition>
  <arm_group>
    <arm_group_label>Bifrontal ECT (BF)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Formula-based low dose BF ECT</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Right unilateral ECT (RU)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Formula-based high-dose RU ECT</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ECT</intervention_name>
    <description>Bifrontal ECT, low dosage</description>
    <arm_group_label>Bifrontal ECT (BF)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ECT</intervention_name>
    <description>Right unilateral electrode position, high dosage</description>
    <arm_group_label>Right unilateral ECT (RU)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Major depression, either unipolar or bipolar.

          -  Competent to give informed consent.

          -  Passing a thorough physical examination

        Exclusion Criteria:

          -  Previous ECT non - response

          -  ECT given during last 6 months

          -  Ongoing substance abuse

          -  Rapid cycling bipolar or schizoaffective disorder

          -  Parkinsons disease

          -  Cognitive impairment (MMSE &lt; 24/30)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lars Tanum, Dr.Med.</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Akershus</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Diakonhjemmet Hospital, Department of Old Age Psychiatry</name>
      <address>
        <city>Oslo</city>
        <zip>0854</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <reference>
    <citation>van der Wurff FB, Stek ML, Hoogendijk WJ, Beekman AT. The efficacy and safety of ECT in depressed older adults: a literature review. Int J Geriatr Psychiatry. 2003 Oct;18(10):894-904. Review.</citation>
    <PMID>14533122</PMID>
  </reference>
  <reference>
    <citation>Tielkes CE, Comijs HC, Verwijk E, Stek ML. The effects of ECT on cognitive functioning in the elderly: a review. Int J Geriatr Psychiatry. 2008 Aug;23(8):789-95. doi: 10.1002/gps.1989. Review.</citation>
    <PMID>18311845</PMID>
  </reference>
  <reference>
    <citation>Gardner BK, O'Connor DW. A review of the cognitive effects of electroconvulsive therapy in older adults. J ECT. 2008 Mar;24(1):68-80. doi: 10.1097/YCT.0b013e318165c7b0. Review.</citation>
    <PMID>18379338</PMID>
  </reference>
  <reference>
    <citation>Kellner CH, Tobias KG, Wiegand J. Electrode placement in electroconvulsive therapy (ECT): A review of the literature. J ECT. 2010 Sep;26(3):175-80. doi: 10.1097/YCT.0b013e3181e48154. Review.</citation>
    <PMID>20562639</PMID>
  </reference>
  <reference>
    <citation>Kellner CH, Knapp R, Husain MM, Rasmussen K, Sampson S, Cullum M, McClintock SM, Tobias KG, Martino C, Mueller M, Bailine SH, Fink M, Petrides G. Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial. Br J Psychiatry. 2010 Mar;196(3):226-34. doi: 10.1192/bjp.bp.109.066183.</citation>
    <PMID>20194546</PMID>
  </reference>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 19, 2012</study_first_submitted>
  <study_first_submitted_qc>March 20, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 21, 2012</study_first_posted>
  <last_update_submitted>July 8, 2015</last_update_submitted>
  <last_update_submitted_qc>July 8, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 9, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Diakonhjemmet Hospital</investigator_affiliation>
    <investigator_full_name>Gro Strømnes Dybedal</investigator_full_name>
    <investigator_title>Ph.D.Student and Clinical Neuropsychologist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

